Artificial intelligence (AI) may help design better CAR T-cell therapies to treat myeloma and other cancers, a study showed. An AI-designed CAR…
Myeloma
“But you look great!” Have you ever heard some variation of that? I have. I confess, I’ve even said it. I think it’s a natural…
Treatment with Tecvayli (teclistamab), an approved cancer drug, can reduce the risk of disease progression in people with high-risk smoldering multiple myeloma, an…
I wake up before the sun and start building the day. First the tea. Then the medication list. Then the careful arrangement of pillows…
Bristol Myers Squibb‘s experimental cell therapy arlocabtagene autoleucel (arlo-cel) may help control myeloma that has returned or failed…
I sit in the doctor’s office translating between two languages. The oncologist speaks in medical terms — “progression-free survival,” “bispecific antibody therapy,” “osteolytic lesions,” “minimal…
Since the late 1940s, when the first chemotherapies were introduced, advances in treatment for blood cancers have resulted in an estimated 25.8 million life-years…
There are many treatments now available for multiple myeloma. Quadruplet therapy, bispecific therapy, CAR T-cell therapy, and cereblon E3 ligase modulators (CELMoDs)…
September is Blood Cancer Awareness Month, and advocates around the world are joining together to shine a light on blood cancer and fundraise to…
A new CAR T-cell therapy designed to target multiple myeloma while sparing healthy immune cells has been given to its first patient in a…
Recent Posts
- Study finds home transfusions safe in hospice care for blood cancer
- Small acts of defiance are the ways we push back against disease
- Under-the-skin myeloma treatment linked to better survival in study
- Add-on therapy shows promise for hard-to-treat AML
- When the caregiver role starts to feel like a second skin